MSMikhail Valerevich Sinitsyn

Mikhail Valerevich Sinitsyn

*This is an algorithmically generated author record based on publicly available information.

Mikhail Valerevich Sinitsyn has a total of 189 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • In vitro evaluation of antimycobacterial activity of bioresorbable implants impregnated with silver nanoparticles and antimycobacterial drugs in the treatment of pulmonary tuberculosis

    by Mikhail V. Sinitsyn, Timur K. Tokaev, Aleksander S. Bikbaev, Platon I. Eliseev, Yury D. Zagoskin, Timofei E. Grigoriev

    Objective: To evaluate the antimycobacterial activity of bioresorbable implants based on polylactide (PLA), polycaprolactone (PCL), and chitosan, impregnated with silver nanoparticles and antituberculosis drugs (ATDs). Materials and methods. The in vitro study included two experiments, each repeated three times. We studied bioresorbable implants based on PLA/PCL and chitosan, impregnated with silver nanoparticles, silver proteinate, or one of seven ATDs (delamanid, linezolid, bedaquiline, moxifloxacin, capreomycin, isoniazid, amikacin). Antimycobacterial activity was assessed by agar diffusion, in the BD BACTEC™ MGIT™ Mycobacterial System, and by broth microdilution using the Mycobacterium tuberculosis H37Rv reference strain. Results. High concentrations of silver nanoparticles (0.034-0.042 nmol/mL) demonstrated bactericidal activity lasting for 35 days. Silver proteinate exerted a slight inhibitory effect on the growth of M. tuberculosis, delaying its growth for only 5 days vs. the control. ATDs, with the exception of delamanid, were released within the first 1-3 days and exhibited bactericidal activity against M. tuberculosis, after which their antimycobacterial activity decreased. Conclusions. Implants impregnated with silver nanoparticles provided a prolonged bactericidal effect against M. tuberculosis, which justifies further study of these implants.

  • Evaluation of the in vitro antimycobacterial activity of bioresorbable implants impregnated with silver nanoparticles and antimycobacterial drugs in the pulmonary tuberculosis treatment

    by Mikhail V. Sinitsyn, Timur K. Tokaev, Alexander S. Bikbaev, Platon I. Eliseev, Yuriy D. Zagoskin, Timofei E. Grigoriev

    Objective: to evaluate the antimycobacterial activity of implants based on polylactide (PLA), polycaprolactone (PCL), and chitosan impregnated with silver nanoparticles and antituberculosis drugs (ATDs). Material and methods. This in vitro study comprised two experiments, each performed in triplicate. Bioresorbable implants based on PLA/PCL and chitosan impregnated with silver nanoparticles, silver proteinate, or one of seven ATDs (delamanid, linezolid, bedaquiline, moxifoxacin, capreomycin, isoniazid, amikacin) were investigated. Antimycobacterial activity was assessed by agar difusion, BACTEC MGIT 960, and broth microdilution using the Mycobacterium tuberculosis H37Rv reference strain. Results. Silver nanoparticles at high concentration (0.034–0.042 nmol/mL) demonstrated bactericidal activity lasting 35 days. Silver proteinate showed only marginal inhibitory efect against M. tuberculosis, delaying culture growth by 5 days compared to the control. ATDs, with the exception of delamanid, were released within the frst 1–3 days and exhibited bactericidal activity against M. tuberculosis, after which antimycobacterial activity declined. Conclusion. Implants impregnated with silver nanoparticles provided a prolonged bactericidal efect against M. tuberculosis, which justifes the need for further investigation of these implants.

  • Efficacy of surgical intervention in modern complex treatment for tuberculosis with multidrug-resistant and extensively drug-resistant pathogen

    by S. A. Kosenkov, D. A. Ivanova, M. V. Sinitsyn

    Background . One of the top priorities in phthisiology at present is the problem of tuberculosis treatment with multiple drug resistance (MDR) and extensive drug resistance (XDR) Mycobacterium tuberculosis (MBT). The unsatisfactory results of etiotropic chemotherapy associated with a large number of factors determine the need for surgical treatment. The effectiveness of surgical treatment and the advantages of using surgical techniques (in combination with chemotherapy) compared to the use of chemotherapy alone, it is currently poorly understood and undoubtedly requires research at various levels. The aim . Evaluation of the effectiveness and determination of optimal timing and risks of surgical intervention in the framework of complex treatment of tuberculosis with MDR/XDR pathogen using modern chemotherapy regimens. Materials and methods . The data on the treatment outcomes of 71 patients with MDR/XDR pathogen after surgery who received identical modern chemotherapy regimens (including bedaquiline, linezolid, fluoroquinolones, cycloserine) with a catamnesis of sufficient duration (at least 5 years) were analyzed. Results . Successful treatment outcome (cure with transfer to the III GDN or de-registration) was registered in 83.1 % (95% CI 72.6-90.2 %). One independent risk factor for an unfavorable outcome was identified - the presence of behavioral characteristics of the patient, indicating his low adherence to treatment (p = 0.014). For relapse, the only independent risk factor was taking less than 90 doses of drugs according to the treatment regimen for drug-resistant tuberculosis, including bedaquiline and linezolid before surgery (p = 0.013). Conclusion . The high efficiency of complex treatment during surgical intervention against the background of MDR/XDR-tuberculosis chemotherapy regimens with the inclusion of bedaquiline and linezolid has been shown. The priority role of working with patients' commitment to treatment for the prevention of adverse outcomes has been confirmed. The optimal duration of preoperative chemotherapy according to the “new” regimens (3 months or more) has been determined.

  • Open Access

    Surgical Aspects of Diagnosis and Treatment of Pulmonary Mycobacteriosis

    by M. V. Sinitsyn, D. M. Kutuzova, V. N. Zimina, I. A. Vasilyeva

    The objective: to study results of using surgical methods for diagnosis and treatment of pulmonary mycobacteriosis. Subjects and Methods. The study was conducted in Thoracic Surgery Department of National Medical Research Center of Phthisiopulmonology and Infectious Diseases, Russian Ministry of Health, from 2022 to 2024. The data of 29 patients with pulmonary mycobacteriosis were analyzed. All those patient underwent surgical treatment, 22 patients had it for therapeutic and diagnostic purposes, and 7 for therapeutic purposes only. Non-tuberculous mycobacteria (NTMB) from specimens were detected by fluorescence microscopy, molecular genetic methods, and culture on liquid nutrient media. When isolating NTMB culture, mass spectrometry was used for species identification. Results. In 22 patients with suspected pulmonary mycobacteriosis without bacteriological confirmation before surgery, 16 segmentectomies, 4 lobectomies, and 2 combined resections were performed. By culture of surgical specimens on liquid nutrient media, growth of NTMB was obtained in 9/22 (40.9%) patients. The species spectrum of NTMB included M. chimaera intracellulare group, M. xenopi, and M. kansasii (3 cases each, 33.3%). Using the molecular genetic method, NTMBs were obtained in 20/22 (91%) patients.


  • Open Access

    Possibilities of endoscopic diagnosis of opportunistic infections in patients with HIV/tuberculosis co-infection

    by M. V. Sinitsyn, S. V. Bykov, M. N. Reshetnikov, A. B. Peregudova, G. N. Kholmogorova, P. A. Bravyi

    Aim of the study : To establish the incidence of opportunistic infections (OI) in patients with HIV/tuberculosis co-infection depending on the severity of immunosuppression and to evaluate the role of endoscopy in the diagnosis of concomitant diseases. Materials and methods : A retrospective analysis was performed of the inpatient medical records of 170 patients with HIV/tuberculosis co-infection in 2023 who underwent diagnostic bronchoscopy and esophagogastroduodenoscopy with sampling for the diagnosis of OI. Results : The spectrum and frequency of occurrence of concomitant OIs, except for tuberculosis, were as follows:esophageal candidiasis in 37 patients (21.8%), CMV infection in 24 patients (14.2%), Pneumocystis pneumonia in 6 patients (3.6%), mycobacteriosis in 4 patients (2.4%), Kaposi's sarcoma in 4 patients (2.4%), and CNS toxoplasmosis in 2 patients (1.2%). The sensitivity and specificity of endoscopic biopsy for the diagnosis of esophageal candidiasis was 100%; Pneumocystis pneumonia and pulmonary mycobacteriosis were verified in 100% of cases using bronchoalveolar lavage. A comparative analysis of the frequency of secondary infectious lesions depending on the form of pulmonary tuberculosis showed that patients with disseminated tuberculosis were more often diagnosed with esophageal candidiasis (36.1% of cases, p=0.005), while patients with disseminated tuberculosis and caseous pneumonia were significantly more likely to have manifest CMV infection (13.9% and 50%, respectively, p=0.006).An analysis of the incidence of concomitant diseases in patients with different numbers of CD4 lymphocytes in the blood showed a significant predominance of esophageal candidiasis (p0.05). Conclusions : Thus, endoscopic diagnostic methods have great diagnostic value for identifying acute respiratory infections in patients with HIV/tuberculosis coinfection. Disseminated pulmonary tuberculosis was a significant predictor of the development of such acute respiratory infections as esophageal candidiasis, overt CMV infection, Pneumocystis pneumonia, and mycobacteriosis in patients with late-stage HIV infection.With a decreased CD4 count, the most common findings during examination were candidiasis and overt CMV infection.

  • Diagnostic value of recombinant tuberculosis allergen and T-SPOT for the diagnosis of tuberculosis in patients with HIV infection

    by V. S. Borovitsky, M. V. Sinitsyn, M. V. Gorbunova, S. L. Babak

    The aim of the study . To determine the diagnostic significance of recombinant tuberculosis allergen and T-SPOT for the diagnosis of tuberculosis in patients with HIV infection. Materials and methods . In 25 patients (72.0% (18/25) male and 28.0% (7/25) female), who had verified tuberculosis in combination with HIV infection, an immunological study was performed using the recombinant tuberculosis allergen and the TSPOT test. The statistical modeling method was simple logistic regression, calculating the likelihood ratio for intervals of the number of CD4 lymphocytes. Results and discussion . From the CD4 lymphocyte level of 200 cells/ml, the probability curve of a positive test result with the recombinant tuberculosis allergen increases sharply and, starting from the CD4 lymphocyte level of 600 cells/ml (the minimum threshold of a healthy person), takes on a probability close to 1.0 (100%). For the T-SPOT immunological test, the probability curve of a positive test result is more than 50% at a CD4 lymphocyte level of less than 200 cells/mll, approximately 100 cells/mll, and at a CD4 lymphocyte level slightly above 200 cells/ml, the probability curve approaches 1.0 (100%). Conclusion . In diagnostically difficult cases in a patient with HIV infection, it is preferable to use an immunological test with T-SPOT to detect tuberculosis when the number of CD4 lymphocytes decreases to less than 200 cells/ml.

  • Open Access

    Transsternal Occlusion of the Main Bronchus in Treatment of Complicated Pulmonary Tuberculosis or Postoperative Complications

    by M. V. Sinitsyn, V. D. Parshin, A. V. Itskov, A. S. Bikbaev, T. K. Tokaev, E. Yu. Yakovleva, Е. Ю. Яковлева

    The objective : to evaluate the results of transsternal occlusion of the main bronchus in pulmonary tuberculosis patients, including management of postoperative complications. Subjects and Methods . 58 patients operated on using transsternal access in 2001-2024 were included in the study. Surgery indications were related to the need to perform a staged pneumonectomy in complicated cases of pulmonary tuberculosis or to eliminate a fistula in the stump of the main bronchus after a previous pneumonectomy. Results. Occlusion of the main bronchus, as a stage of surgical treatment (staged operation) was performed in 49 patients, and 9 patients were operated on due to fistula of the main bronchus after pneumonectomy. 28 patients had occlusion of the main bronchus (or the stump of this bronchus) on the right, and 30 patients on the left. Postoperative complications developed in 10/58 (17.2%) patients, of which stump failure occurred in 2/58 (3.4%). 12.2% (6/49) of the patients undergoing staged surgery died: 4 patients died from the progression of tuberculosis after transsternal occlusion of the main bronchus until the next stage, and 2 patients died from cardiorespiratory complications after the final pneumonectomy. There were nor complication, neither lethal cases in transsternal occlusion of the main bronchus stump due to fistula (9 patients). Conclusion . Transsternal occlusion of the main bronchus is a well-known method that is used when performing staged pneumonectomies if there is a high risk of bronchial suture failure. Transsternal access to the stump of the main bronchus in postoperative fistulas ensures safety of the intervention in combination with effective occlusion.

  • Open Access

    Diagnostic capacities of the ELISPOT laboratory method in the detection of tuberculosis infection in the study of bronchoalveolar lavage fluid

    by T. V. Vaneeva, S. V. Bykov, M. A. Sviridenko, S. G. Safonova, M. V. Sinitsyn

    Aim. Determine the diagnostic capabilities of the IGRA test system based on the ELISPOT platform in detecting specifically sensitized cells in bronchoalveolar lavage fluid of patients with pulmonary tuberculosis, including patients with HIV infection.Materials and methods. The sensitivity of the ELISPOT laboratory test system was analyzed in the study of bronchoalveolar lavage fluid and peripheral blood from 70 patients with newly diagnosed pulmonary tuberculosis and 31 patients with HIV-tuberculosis coinfection. Samples from each patient were examined by the immunological method using the T-SPOT®.TB test system (Oxford Immunotec Limited, UK).Results. In HIV-negative patients, bronchoalveolar lavage fluid analysis can increase the clinical sensitivity of the laboratory test system to 81.4% (95%CI 70.8-88.8%) compared with peripheral blood analysis (74.3%; 95%CI 63.0-83.1%). In HIV-infected patients, examination of bronchoalveolar lavage fluid resulted in a decrease in the clinical sensitivity of the test system to 61.3% (95% CI 43.8-76.3%) compared with peripheral blood analysis (77.4%, 95%CI 60.2-88.6%; pConclusion. Examination of bronchoalveolar lavage fluid using the T-SPOT® test system.TB helps to increase the detection of tuberculosis infection predominantly in uninfected HIV patients.

  • Open Access

    Spectrum of Drug Resistance of Mycobacterium tuberculosis in the Operated Patients Based on Testing of Resected Specimens of Lung Tissue

    by S. Z. Suleimanov, M. V. Sinitsyn, I. V. Golubenkov, L. E. Parolina, O. V. Lovacheva, I. A. Vasilyeva

    The objective: to compare the spectrum of drug resistance of Mycobacterium tuberculosis obtained from respiratory and surgical specimens of pulmonary tuberculosis patients.Subjects and Methods. A non-randomized, continuous, single-center retrospective study was performed and included 102 patients who underwent surgery at National Medical Research Center of Phthisiopulmonology and Infectious Diseases for drug-resistant pulmonary tuberculosis from 2018 to 2022. Spectrum of drug resistance of Mycobacterium tuberculosis (MTB) isolated from the respiratory and surgical specimens was retrospectively analyzed.Results. When comparing the type and spectrum of drug resistance (DR) of MTB isolated from respiratory samples and surgical specimens, inconsistent results were observed in 47 (46%) of 102 patients, of which 21/102 (20.6%) were diagnosed with primary drug resistance, of them 14 (13.7%) patients had MDR and 7 (6.8%) patients had pre-XDR. The consistency of DR spectrum was more often observed in fibrous cavernous tuberculosis versus tuberculomas – in 13 (76.4%) of 17 patients and in 31 (37.8%) of 82, respectively, p = 0.024 (TTF); OR = 5.34; 95% CI: 1.49-19.1.

  • Open Access

    Risk factors for tuberculosis incidence in Russia and the North Caucasus federal district at the current stage

    by Nikolai V. Kobesov, Mikhail V. Sinitsyn, Zinaida M. Zagdyn, Madina K. Pagieva, Синицин Михаил Валерьевич

    Background. Analysis of risk factors for tuberculosis allows us to assess targeted areas in the fight against tuberculosis. Aim. To analyze risk factors for the spread of tuberculosis in Russia and the North Caucasus Federal District. Materials and methods. The study of risk factors was carried out according to literature data for 2016–2023 and epidemic statistics of tuberculosis for 2018–2022 for Russia and the North Caucasus Federal District. Results. Epidemic indicators of tuberculosis at the present stage are influenced by both endogenous and exogenous factors. Tuberculosis is still a socially significant disease. Social risk factors for tuberculosis include: inaccessible location and remoteness of the place of residence, difficult working and living conditions, marginal behavior, including poor sanitary and financial standards, the presence in a person’s biography of periods of detention in penitentiary institutions, the presence of homeless people, the presence of migrant workers. Medical risk factors for tuberculosis include: alcoholism, drug addiction, nicotine addiction, chronic nonspecific lung diseases, gastric ulcers and gastritis, diabetes mellitus, and oncological pathologies. Some of the above risk factors lead to the emergence of undertreated patients and increase the risk of developing tuberculosis in children who are in close contact with disadvantaged adults. The largest proportion of tuberculosis patients is noted to be of working age 35–44 years. The epidemic intensity of tuberculosis remains due to the presence of hidden and uncontrollable sources of infection in population groups for which anti-tuberculosis measures are difficult or impossible. HIV infection remains the main endogenous risk factor for tuberculosis. Conclusion. HIV infection and the spread of multidrug-resistant tuberculosis lead to the development of infectious foci with new characteristics. The incidence of multidrug-resistant tuberculosis is increasing in Russia and the North Caucasus Federal District; a sharp jump occurred in 2022 compared to 2021. The proportion of patients with a combination of tuberculosis and HIV infection among all patients with tuberculosis is constantly growing.